These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20439957)

  • 1. Dynamics and predictive potential of antibodies against insect-derived recombinant Leishmania infantum proteins during chemotherapy of naturally infected dogs.
    Todolí F; Galindo I; Gómez-Sebastián S; Pérez-Filgueira M; Escribano JM; Alberola J; Rodríguez-Cortés A
    Am J Trop Med Hyg; 2010 May; 82(5):795-800. PubMed ID: 20439957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.
    Nieto CG; García-Alonso M; Requena JM; Mirón C; Soto M; Alonso C; Navarrete I
    Vet Immunol Immunopathol; 1999 Feb; 67(2):117-30. PubMed ID: 10077418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
    Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.
    Solano-Gallego L; Di Filippo L; Ordeix L; Planellas M; Roura X; Altet L; Martínez-Orellana P; Montserrat S
    Parasit Vectors; 2016 May; 9(1):235. PubMed ID: 27160317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment.
    Rhalem A; Sahibi H; Lasri S; Jaffe CL
    Vet Immunol Immunopathol; 1999 Oct; 71(1):69-76. PubMed ID: 10522787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroreactivity against raw insect-derived recombinant KMPII, TRYP, and LACK Leishmania infantum proteins in infected dogs.
    Todolí F; Pérez-Filgueira M; Galindo I; Gómez-Sebastián S; Escribano JM; Rodríguez-Cortés A; Alberola J
    Vet Parasitol; 2009 Oct; 164(2-4):154-61. PubMed ID: 19570612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
    Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
    Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.
    Coelho EA; Ramírez L; Costa MA; Coelho VT; Martins VT; Chávez-Fumagalli MA; Oliveira DM; Tavares CA; Bonay P; Nieto CG; Abánades DR; Alonso C; Soto M
    Clin Vaccine Immunol; 2009 Dec; 16(12):1774-80. PubMed ID: 19812259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
    Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Ludolf F; Steiner BT; Reis TAR; Santos TTO; Costa LE; Martins VT; Galvani NC; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Duarte MC; Menezes-Souza D; Silveira JAG; Moreira RLF; Machado-de-Ávila RA; Tupinambás U; Gonçalves DU; Coelho EAF
    Immunol Lett; 2020 Apr; 220():11-20. PubMed ID: 31981576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay.
    Scalone A; De Luna R; Oliva G; Baldi L; Satta G; Vesco G; Mignone W; Turilli C; Mondesire RR; Simpson D; Donoghue AR; Frank GR; Gradoni L
    Vet Parasitol; 2002 Apr; 104(4):275-85. PubMed ID: 11836028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of three recombinant Leishmania infantum antigens in human and canine visceral leishmaniasis diagnosis.
    Fonseca AM; Faria AR; Rodrigues FT; Nagem RA; Magalhães RD; Cunha JL; Bartholomeu DC; de Andrade HM
    Acta Trop; 2014 Sep; 137():25-30. PubMed ID: 24801885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
    Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and diagnostic and prognostic potential of quantitative Western blot analysis and antigen-specific enzyme-linked immunosorbent assay in experimental canine leishmaniasis.
    Talmi-Frank D; Strauss-Ayali D; Jaffe CL; Baneth G
    Clin Vaccine Immunol; 2006 Feb; 13(2):271-6. PubMed ID: 16467337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum.
    Molano I; Alonso MG; Mirón C; Redondo E; Requena JM; Soto M; Nieto CG; Alonso C
    Vet Immunol Immunopathol; 2003 Mar; 92(1-2):1-13. PubMed ID: 12628759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs.
    Porrozzi R; Santos da Costa MV; Teva A; Falqueto A; Ferreira AL; dos Santos CD; Fernandes AP; Gazzinelli RT; Campos-Neto A; Grimaldi G
    Clin Vaccine Immunol; 2007 May; 14(5):544-8. PubMed ID: 17314229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.
    Soto M; Requena JM; Quijada L; Perez MJ; Nieto CG; Guzman F; Patarroyo ME; Alonso C
    Clin Exp Immunol; 1999 Feb; 115(2):342-9. PubMed ID: 9933463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.
    Todolí F; Solano-Gallego L; de Juan R; Morell P; Núñez Mdel C; Lasa R; Gómez-Sebastián S; Escribano JM; Alberola J; Rodríguez-Cortés A
    Am J Trop Med Hyg; 2010 Dec; 83(6):1287-94. PubMed ID: 21118936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunoproteomic approach to identifying immunoreactive proteins in
    Rashidi S; Mojtahedi Z; Shahriari B; Kalantar K; Ghalamfarsa G; Mohebali M; Hatam G
    Pathog Glob Health; 2019 May; 113(3):124-132. PubMed ID: 31099725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial.
    Gómez-Ochoa P; Castillo JA; Gascón M; Zarate JJ; Alvarez F; Couto CG
    Vet J; 2009 Feb; 179(2):259-63. PubMed ID: 18023375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.